Clinical Trials Directory

Trials / Completed

CompletedNCT01822132

Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this protocol is to learn more about impulsive decision making in people who use methamphetamines. The investigators would like to know if a medication called naltrexone changes how people make decisions. The investigators would also like to know whether changes in decision making can be observed by MRI (magnetic resonance imaging). The research is conducted in Portland, OR.

Conditions

Interventions

TypeNameDescription
DRUGExtended release naltrexone
DRUGPlacebo

Timeline

Start date
2013-05-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2013-04-02
Last updated
2019-03-05
Results posted
2019-02-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01822132. Inclusion in this directory is not an endorsement.